Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.


Listen to the latest hemonc news from international experts

The importance of early interception and intervention in myeloma

Multiple myeloma is a heterogenous and complex disease, with many experts agreeing that screening for precursor conditions can improve patient outcomes. With several new technologies emerging and an increased understanding of precursor conditions, it is evident that early intervention and interception are important steps in finding a cure for this disease.

In this exclusive podcast, Irene Ghobrial, MD, of Dana-Farber Cancer Institute, Boston, MA, discusses the importance of early interception in multiple myeloma and how screening and risk stratification can help with finding a cure.

Date: 7th June 2022

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter